News
XOMA Corp Entered Into A Merger Agreement To Acquire Kinnate Biopharma For A Base Cash Price Per Share Of $2.3352 Per Share And An Additional Cash Amount Of Not More Than $0.2527 Per Share
19 Mar 24
M&A
Kinnate Biopharma Inc. Sells Its Investigational Pan-RAF Inhibitor, Exarafenib, To Pierre Fabre Laboratories For A Total Consideration Of Up To $31M
1 Mar 24
News, Asset Sales
Biotech Royalty Aggregator XOMA To Acquire Small Cancer-Drug Developer Kinnate Biopharma
16 Feb 24
Biotech, M&A, News, Health Care, Movers, Trading Ideas, General
Press releases
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates FREE, SCTL, KNTE
20 Mar 24
News, Legal, Press Releases
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates FREE, HRT, NGM, KNTE
18 Mar 24
Press Releases
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates FANG, FREE, KNTE
16 Mar 24
Press Releases
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates KNTE, DOOR, HMST
13 Mar 24
News, Legal, Press Releases
KINNATE BIOPHARMA INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Kinnate Biopharma Inc. - KNTE
13 Mar 24
Press Releases
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates DOOR, FREE, KNTE
12 Mar 24
Press Releases
SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Continues Investigating the Merger - EVBG, TAST, ZFOX, KNTE
11 Mar 24
Penny Stocks, Press Releases
INVESTIGATION UPDATE: Halper Sadeh LLC Investigates CTLT, EVBG, FREE, KNTE
9 Mar 24
Press Releases
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates HAYN, KNTE, SCTL
5 Mar 24
Press Releases
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates AA, NGM, KNTE
2 Mar 24
Press Releases
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into the Fairness of the Acquisition of Kinnate Biopharma Inc. by XOMA Corporation
1 Mar 24
News, Legal, Press Releases
Kinnate Biopharma Inc. Sells Its Investigational Pan-RAF Inhibitor, exarafenib, to Pierre Fabre Laboratories
1 Mar 24
Press Releases
Kinnate Biopharma Inc. Sells Its Investigational Pan-RAF Inhibitor, Exarafenib, to Pierre Fabre Laboratories
1 Mar 24
News, Financing, Contracts, Press Releases
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates NGM, AA, HRT, KNTE
26 Feb 24
Press Releases
Thinking about buying stock in Idaho Strategic Resources, Angi, Alarm.com, Kinnate Biopharma, or Quanta Services?
26 Feb 24
Opinion, Press Releases
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates HRT, DFS, COF, KNTE
24 Feb 24
Press Releases
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates DFS, COF, KNTE
21 Feb 24
Press Releases
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates KNTE, CTLT
19 Feb 24
News, Legal, Press Releases
KINNATE BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Kinnate Biopharma Inc. - KNTE
19 Feb 24
Press Releases
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Kinnate Biopharma Inc.
16 Feb 24
Press Releases